Black Swift Group LLC Increases Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Black Swift Group LLC boosted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 34.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 106,500 shares of the construction company’s stock after purchasing an additional 27,100 shares during the quarter. Black Swift Group LLC owned approximately 0.14% of Aspen Aerogels worth $2,949,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Driehaus Capital Management LLC raised its position in shares of Aspen Aerogels by 130.4% during the 2nd quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after purchasing an additional 1,220,724 shares during the last quarter. American Century Companies Inc. raised its holdings in shares of Aspen Aerogels by 562.3% during the second quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of Aspen Aerogels in the second quarter worth approximately $9,339,000. Hood River Capital Management LLC boosted its stake in shares of Aspen Aerogels by 12.2% in the first quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after acquiring an additional 357,895 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Aspen Aerogels during the second quarter worth approximately $8,340,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ASPN. TD Cowen raised their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a report on Tuesday, August 20th. Barclays lowered their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday. HC Wainwright restated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Finally, Piper Sandler dropped their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $28.70.

Insider Activity

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Price Performance

ASPN stock opened at $15.52 on Thursday. The business’s fifty day moving average price is $22.44 and its 200 day moving average price is $24.67. Aspen Aerogels, Inc. has a 12-month low of $9.89 and a 12-month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.82 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $1.27 billion, a PE ratio of 1,553.55 and a beta of 2.21.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.